Nuclear receptor Nur77 suppresses inflammatory response dependent on COX-2 in macrophages induced by oxLDL

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 2, 2010, Pages 304-311

  Shao, Qin ^a   Shen, Ling Hong ^a   Hu, Liu Hua ^a   Pu, Jun ^a   Qi, Mei Yan ^b   Li, Wen Qing ^b   Tian, Fu Ju ^b   Jing, Qing ^b   He, Ben ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

Atherosclerosis; COX 2; Macrophages; Nur77; OxLDL

Indexed keywords

CYCLOOXYGENASE 2; MERCAPTOPURINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEAR RECEPTOR NUR77; OXIDIZED LOW DENSITY LIPOPROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CELL LINE; CHEMOKINES; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; MACROPHAGES; MICE; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; P38 MITOGEN-ACTIVATED PROTEIN KINASES; UP-REGULATION;

MURINAE;

EID: 77953722723     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.03.023     Document Type: Article

References (32)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
2. Kirii Hirokazu, Niwa Tamikazu, Yamada Yasuhiro Lack of Interleukin-1β decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23:656-660.
3. Shen L.H., Zhou L., Wang B.Y., Pu J., Hu L.H., Chai D.J., et al. Oxidized low-density lipoprotein induces differentiation of RAW264.7 murine macrophage cell line into dendritic-like cells. Atherosclerosis 2008, 199:257-264.
4. Pei L., Castrillo A., Chen M., Hoffmann A., Tontonoz P. Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem 2005, 280:29256-29262.
5. Bonta P.I., van Tiel C.M., Vos M., Pols T.W., van Thienen J.V., Ferreira V., et al. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol 2006, 26:2288-2294.
6. Bensinger S.J., Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 2008, 454:470-477.
7. Evans Paul C. Nur77 orphaned at birth but adopted by the nuclear factor kB signaling pathway. Circ Res 2009, 104:707-709.
8. Bonta P.I., Pols T.W., deVries C.J. NR4A nuclear receptors in atherosclerosis and vein-graft disease. Trends Cardiovasc Med 2007, 17:105-111.
9. Cheng L.E., Chan F.K., Cado D., Winoto A. Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J 1997, 16:1865-1875.
10. Lin B., Kolluri S.K., Lin F., Liu W., Han Y.H., Cao X., et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 2004, 116:527-540.
11. Zetterstrom R.H., Solomin L., Jansson L., Hoffer B.J., Olson L., Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science 1997, 276:248-250.
12. Martinez-Gonzalez J., Badimon L. The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. Cardiovasc Res 2005, 65:609-618.
13. Hsu H.C., Zhou T., Mountz J.D. Nur77 family of nuclear hormone receptors. Curr Drug Targets-Inflamm Allergy 2004, 3:413-423.
14. Hu L.H., He B., Shen L.H., Zhou L., Pu J., Jiang L.S., et al. Nuclear receptor Nur77 inhibits oxidized low density lipoprotein induced lipid loading in macrophages. Zhonghua Xin Xue Guan Bing Za Zhi 2008, 36:1032-1036.
15. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci 1984, 81:3883-3887.
16. Taketa K., Matsumura T., Yano M., Ishii N., Senokuchi T., Motoshima H., et al. Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-α (PPARα) and PPARγ through MAPK-dependent COX-2 expression in macrophages. J Biol Chem 2008, 283:9852-9862.
17. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
18. Wansa K.D., Harris J.M., Yan G., Ordentlich P., Muscat G.E. The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite, 6-mercaptopurine. J Biol Chem 2003, 278:24776-24790.
19. Burleigha M.E., Babaevb V.R., Yanceyb P.G., Majorb A.S., McCalebb J.L., Oatesa J.A., et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice. J Mol Cell Cardiol 2005, 39(3):443-452.
20. Wilson T.E., Fahrner T.J., Johnston M., Milbrandt J. Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science 1991, 252:1296-1300.
21. Arkenbout E.K., de Waard V., van Bragt M., van Achterberg T.A., Grimbergen J.M., Pichon B., et al. Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation 2002, 106:1530-1535.
22. de Waard V., Arkenbout E.K., Vos M., Mocking A.I., Niessen H.W., Stooker W., et al. TR3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells. Am J Pathol 2006, 168:2027-2035.
23. Pires N.M., Pols T.W., de Vries M.R., van Tiel C.M., Bonta P.I., Vos M., et al. Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation. Circulation 2007, 115:493-500.
24. Zeng H., Qin L., Zhao D., Tan X., Manseau E.J., Van Hoang M., et al. Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med 2006, 203:719-729.
25. You B., Jiang Y.-Y., Chen S., Yan G., Sun J. The orphan nuclear receptor Nur77 suppresses endothelial cell activation through induction of IkBα expression. Circ Res 2009, 104:742-749.
26. Blake G.J., Ridker P.M. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002, 252:283-294.
27. Tabas I. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Cell Death Differ 2004, 11:s12-s16.
28. Nakashima S. Protein kinase C alpha (PKC alpha): regulation and biological function. J Biochem 2002, 132:669-675.
29. Tsatsanis C., Androulidaki A., Venihaki M., Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 2006, 38:1654-1661.
30. Senokuchi T., Matsumura T., Sakai M., Matsuo T., Yano M., Kiritoshi S., et al. Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein. Atherosclerosis 2004, 176:233-245.
31. Pei L., Castrillo A., Tontonoz P. Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol Endocrinol 2006, 20:786-794.
32. Burleigh M.E., Babaev V.R., Oates J.A., Harris R.C., Gautam S., Riendeau D., et al. Cyclooxygenase2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 2002, 105:1816-1823.